Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

68
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
68
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

167
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
167
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

76
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Dilinoleic Succinate Segments on the Biodegradation of Poly(butylene succinate-<i>co</i>-dilinoleic succinate) Copolymers under Composting and Anaerobic Digestion Conditions.

ACS omega·2026
Same author

Congenital long QT syndrome in the pregnant women: a systematic review.

Ginekologia polska·2026
Same author

Erratum: Evaluating the<i>in vivo</i>glial response to miniaturized parylene cortical probes coated with an ultra-fast degrading polymer to aid insertion (2018<i>J. Neural Eng</i>.<b>15</b>036002).

Journal of neural engineering·2026
Same author

Comparison of Total Laparoscopic Hysterectomy and Total Abdominal Hysterectomy in Endometrial Cancer: A Retrospective Single-Centre Cohort Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Nature communications·2026
Same author

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab.

Cancers·2026

Related Experiment Video

Updated: Mar 14, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K

New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.

Anita Chudecka-Głaz1, Joanna Szczeblińska2, Aneta Cymbaluk-Płoska1

  • 1a Chair and Department of Gynaecological Surgery and Gynaecological Oncology of Adults and Adolescents , Pomeranian Medical University , Szczecin , Poland.

Journal of Microencapsulation
|October 6, 2016
PubMed
Summary

New poly(ester-amide)-poly(ethylene glycol) copolymers effectively encapsulate the chemotherapy drug carboplatin. These advanced materials enable controlled drug release, offering potential for targeted cancer therapy.

Keywords:
Biodegradable polymersdrug releasemicroencapsulationpolymer synthesis

More Related Videos

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by &#960;-&#960; Stacking Interactions
10:53

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

14.7K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.6K

Related Experiment Videos

Last Updated: Mar 14, 2026

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K
Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by &#960;-&#960; Stacking Interactions
10:53

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

14.7K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.6K

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Developing novel polymeric materials for effective drug encapsulation is crucial for targeted cancer therapy.
  • Poly(ester-amide) copolymers offer tunable properties for biomedical applications.
  • Poly(ethylene glycol) modification can enhance biocompatibility and drug release profiles.

Purpose of the Study:

  • To synthesize and characterize novel poly(ester-amide)-poly(ethylene glycol) (PEG) copolymers.
  • To evaluate the potential of these copolymers for carboplatin encapsulation and controlled release.
  • To investigate the influence of PEG molecular weight on drug release kinetics.

Main Methods:

  • Synthesis of poly(ester-amide) copolymers with hydrophobic (tyrosine derivative, dimer fatty acid) and hydrophilic (PEG) blocks.
  • Fabrication of drug-loaded microspheres using a double emulsification technique.
  • In vitro degradation studies in simulated body fluid.
  • Carboplatin release studies and kinetic analysis using mathematical models.

Main Results:

  • The developed copolymers exhibited high water absorption and an erosive degradation mechanism.
  • Microspheres with an average diameter of 20-30 μm were successfully prepared.
  • Drug release rate was significantly influenced by the molecular weight of the incorporated PEG.
  • Mathematical modeling elucidated the carboplatin release mechanism from the microspheres.

Conclusions:

  • Poly(ester-amide)-PEG copolymers are promising biomaterials for carboplatin encapsulation.
  • The tunable nature of these copolymers allows for controlled drug release profiles.
  • These materials hold potential for developing targeted drug delivery systems for cancer treatment.